Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Levocarnitine Oral Solution

Approval Number

国药准字HJ20171307

CompanyALFASIGMA SPA

Registration Date

January 26, 2025

Previous Approval Numbers

H20171307

Drug Information

Generic Name

左卡尼汀口服溶液

Dosage Form

口服溶液剂

Strength

10ml: 1g

Drug Type

化学药品

Registration Date

January 26, 2025

Expiry Date

January 25, 2030

Company Information

Applicant Company

Company NameALFASIGMA SPA

Company Address

VIA RAGAZZI DEL 99 N°5-40133 BOLOGNA-ITALIA

Manufacturing Company

Company NameALFASIGMA SPA

Company Address

Via Pontina Km 30,400-00071 Pomezia（RM）

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

左卡尼汀口服溶液 - NMPA 批准文号 | MedPath